1
Three patients had atypical carcinoids, one with multiple endocrine neoplasia type 1 syndrome.
2
Pituitary adenomas represent one of the key features of multiple endocrine neoplasia type 1.
3
She was diagnosed as having multiple endocrine neoplasia type 1 with gastrinoma and liver metastases.
4
At diagnosis, all patients were checked for the presence of multiple endocrine neoplasia type I syndrome.
5
One patient presented with multiple endocrine neoplasia syndrome.
6
The multiple endocrine neoplasia syndromes are an association of tumours of 2 or more endocrine glands.
7
Eight patients had sporadic NETs, and 1 had multiple endocrine neoplasia type 1 syndrome.
8
Medullary thyroid carcinoma is the most common cause of death among patients with multiple endocrine neoplasia (MEN) 2.
9
The diagnosis of medullary thyroid carcinoma by biochemical and genetic testing is possible in families with multiple endocrine neoplasia type 2.
10
Combined biochemical and genetic screening for multiple endocrine neoplasia type 2 is important and effective for the cure of medullary thyroid carcinoma.
11
All were symptomatic at presentation except one who had multiglandular involvement as a part of multiple endocrine neoplasia (MEN)-I screening.
12
Of the 43 pheochromocytomas, 16 were neoplasms inherited in the setting of multiple endocrine neoplasia type 2A.
13
Multiple endocrine neoplasia (MEN) syndromes are autosomal-dominant genetic disorders that predispose two or more organs of the endocrine system to tumor development.
14
Early diagnosis of multiple endocrine neoplasia (MEN) syndromes is critical for optimal clinical outcomes; before the MEN syndromes can be diagnosed, they must be suspected.
15
Multiple endocrine neoplasia type 1 (MEN1) is a rare disease caused by mutations in the MEN1 gene on chromosome 11.
16
Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome characterized by development of multiple endocrine tumors in affected individuals.
